BARRECA, Marilia
 Distribuzione geografica
Continente #
NA - Nord America 1.876
EU - Europa 355
AS - Asia 72
OC - Oceania 4
AF - Africa 3
SA - Sud America 2
Totale 2.312
Nazione #
US - Stati Uniti d'America 1.869
IT - Italia 215
FR - Francia 48
DE - Germania 25
GB - Regno Unito 21
CN - Cina 18
JP - Giappone 16
IN - India 12
NL - Olanda 9
AT - Austria 8
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
HK - Hong Kong 6
CA - Canada 4
FI - Finlandia 4
UA - Ucraina 4
AU - Australia 3
EG - Egitto 3
IL - Israele 3
MX - Messico 3
PT - Portogallo 3
SE - Svezia 3
BE - Belgio 2
CO - Colombia 2
GR - Grecia 2
IQ - Iraq 2
SA - Arabia Saudita 2
TW - Taiwan 2
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
IE - Irlanda 1
LB - Libano 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
SG - Singapore 1
TH - Thailandia 1
TR - Turchia 1
Totale 2.312
Città #
Ashburn 1.654
Palermo 118
Milan 27
Fairfield 14
Santa Cruz 14
Boardman 12
Columbus 9
Des Moines 9
Cambridge 8
Vienna 8
Woodbridge 8
Seattle 6
Council Bluffs 5
Rome 5
Ann Arbor 4
Arzignano 4
Bristol 4
Grenoble 4
Houston 4
Las Vegas 4
London 4
Los Angeles 4
Paris 4
San Diego 4
Tokyo 4
Turin 4
Atlanta 3
Bengaluru 3
Capaci 3
Carini 3
Cedar Knolls 3
Chicago 3
Favara 3
Helsinki 3
Lisbon 3
Lugano 3
Osaka 3
San Francisco 3
The Hague 3
Bari 2
Basrah 2
Beijing 2
Berlin 2
Buffalo 2
Central 2
Chennai 2
Chino 2
Fisciano 2
Genoa 2
Hong Kong 2
Islington 2
Medellín 2
Mumbai 2
Naples 2
New York 2
Newcastle upon Tyne 2
Padova 2
Riva Trigoso 2
Riyadh 2
Rochester 2
Shanghai 2
Shenzhen 2
Silver Spring 2
Taipei 2
Thrissur 2
Zurich 2
Adelaide 1
Agrigento 1
Ahmedabad 1
Alfortville 1
Amstelveen 1
Ankara 1
Assiut 1
Aurora 1
Beirut 1
Brooklyn 1
Brussels 1
Cagliari 1
Cairo 1
Calgary 1
Catanzaro 1
Chadds Ford 1
Changsha 1
Cholula 1
Christchurch 1
City of London 1
Cologne 1
Copenhagen 1
Coppell 1
Covington 1
Dallas 1
Darlington 1
Dublin 1
Evanston 1
Eygelshoven 1
Fayetteville 1
Fremont 1
Garching 1
Giubiasco 1
Giv‘at Shmuel 1
Totale 2.072
Nome #
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences, file 34714d0f-4d27-4268-8c8c-3699346c8a5f 1.613
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes, file e3ad8924-1bb5-da0e-e053-3705fe0a2b96 70
An overview on anti-tubulin agents for the treatment of lymphoma patients, file 075b03fb-3bbf-4005-8b84-8f41715bbe30 69
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein, file e3ad8925-f229-da0e-e053-3705fe0a2b96 68
GPCR Inhibition in Treating Lymphoma, file e3ad8927-c0b0-da0e-e053-3705fe0a2b96 67
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma, file 2bee4c80-3765-4478-b2a8-72b71af7ea5c 63
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line, file 595a0f5d-cc8b-49e7-88a7-4385e92108a2 43
Current development of CFTR potentiators in the last decade, file 47b20b1d-83ea-4b4e-b11c-00c8cf22de01 40
Editorial: Emerging heterocycles as bioactive compounds, file 44360a8d-7b79-4a59-845d-0c3bb6b2bf00 34
[1,2]OXAZOLE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST MULTIPLE MALIGNANT CELL TYPES, file e3ad8926-211a-da0e-e053-3705fe0a2b96 32
THE KEY ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTICANCER THERAPIES: A PILOT STUDY IN THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER, file e3ad8927-caef-da0e-e053-3705fe0a2b96 19
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma, file 0e9fa3d8-c987-4563-a711-b2067f5567e1 18
New tricyclic systems as photosensitizers towards triple negative breast cancer cells, file 68943775-456d-421b-a69d-3b02f811ddf6 18
Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity, file 208c255f-bcac-432b-9e5c-984290b7f8d0 16
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors, file 06fd1189-8eb6-488d-869b-59d46a2b462b 13
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma, file 60a8aa38-45a1-4a2f-8fd3-8182b9c00022 11
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors, file e3ad8924-52a3-da0e-e053-3705fe0a2b96 11
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel, file 40020b01-bfd4-4fbd-b3cb-1a13129bd1b1 10
Current development of CFTR potentiators in the last decade, file e3ad8922-e362-da0e-e053-3705fe0a2b96 10
Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types, file e3ad8923-3ea9-da0e-e053-3705fe0a2b96 10
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells, file e3ad8922-f230-da0e-e053-3705fe0a2b96 9
Secondary resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma, file e3ad8925-19b2-da0e-e053-3705fe0a2b96 8
Screening of fractions from marine sponges and other invertebrates to identify new lead compounds with anti-tumor activity in lymphoma models, file e3ad8925-4ee7-da0e-e053-3705fe0a2b96 8
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis, file 185bcbc0-38f3-478d-9329-f6a33f4ceb9e 7
Advances in developing noncovalent small molecules targeting Keap1, file 39c15396-3231-4c2a-85bf-a7c82b4d1368 7
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas, file 3be6e496-67f3-4594-809a-53a44ae1471f 7
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches, file 9ad5fb73-de03-482d-8582-ddf1bed6115a 7
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells, file e3ad8928-cbcb-da0e-e053-3705fe0a2b96 5
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib, file 67c40f2a-4b89-47fc-ba82-0b9ff66b4feb 4
An overview on anti-tubulin agents for the treatment of lymphoma patients, file e3ad8924-1570-da0e-e053-3705fe0a2b96 4
GPCR Inhibition in Treating Lymphoma, file 22a140c1-5371-40b2-a3e6-797bee8a0b69 3
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas, file 39dae90d-10e8-4886-b6e4-87fe607b299a 3
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors, file ab0ee415-277c-4a82-b6a0-20c27a2934e1 3
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis, file 8b5fe29b-3525-4f07-be59-7b05ef6cee40 2
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations, file e3ad8928-9c4d-da0e-e053-3705fe0a2b96 2
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas, file 86bd1a22-5a6e-4d81-8dbd-acb498c09bee 1
Totale 2.315
Categoria #
all - tutte 5.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 4 0 2 0 16 7 4 0 4 16
2021/202269 2 6 2 2 2 3 7 3 9 8 17 8
2022/2023243 4 8 24 20 19 20 21 14 16 26 57 14
2023/20241.950 7 19 24 33 13 28 1.705 39 52 22 8 0
Totale 2.315